Environmental exposures during early life, but not during adolescence or adulthood, lead to persistent reductions in neurogenesis in the adult hippocampal dentate gyrus (DG). The mechanisms by which early life exposures lead to long-term deficits in neurogenesis remain unclear. Here, we investigated whether targeted ablation of dividing neural stem cells during early life is sufficient to produce long-term decreases in DG neurogenesis. Having previously found that the stem cell lineage is resistant to long-term effects of transient ablation of dividing stem cells during adolescence or adulthood (Kirshenbaum, Lieberman, Briner, Leonardo, & Dranovsky, 2014), we used a similar pharmacogenetic approach to target dividing neural stem cells for elimination during early life periods sensitive to environmental insults. We then assessed the Nestin stem cell lineage in adulthood.
| I N TR ODU C TI ON
Adult hippocampal neurogenesis, which occurs in the dentate gyrus (DG), has been the topic of significant study to understand its regulation and function in health and disease (Cameron and Glover, 2015; Ming and Song, 2005) . While the rodent DG begins to form during the late embryonic period, most of the structure develops during the first two postnatal weeks (Altman and Bayer, 1990; Angevine, 1965; Bayer, 1980; Stanfield and Cowan, 1979) . The majority of granule neurons that comprise the adult rodent DG granule cell layer (GCL) are born during the first week of life (Angevine, 1965; Muramatsu, Ikegaya, Matsuki, & Koyama, 2007) . Accordingly, DG cell proliferation is dramatically higher during this time window compared to later developmental periods (Bayer and Altman, 1974; Muramatsu et al., 2007; NavarroQuiroga, Hernandez-Valdes, Lin, & Naegele, 2006) . Throughout the life-long DG development, new granule neurons arise from Nestin and glial fibrillary acidic protein (GFAP) expressing stem astrocytes (Zhao, Deng, & Gage, 2008) and are added to the GCL. During the first postnatal week, these neural stem cells are diffusely spread in the area that will become the GCL, but as the structure matures, the stem cells condense into the subgranular zone (SGZ) where they remain into adulthood (Nicola, Fabel, & Kempermann, 2015; Sugiyama, Osumi, & Katsuyama, 2013) . The DG develops in an outside-in manner, with neurons born in the embryonic and neonatal periods residing in the outer layer of the GCL and cells born later filling in the middle and inner layers; adult born cells reside in the inner layer adjacent to the SGZ (Mathews et al., 2010; Muramatsu et al., 2007) .
Adult neurogenesis is likely a continuation of the developmental process in the DG (Encinas, Sierra, Valcarcel-Martin, & Martin-Suarez, 2013 ; Kuhn and Blomgren, 2011; Nicola et al., 2015) . By the third week of life in rodents, levels of DG cell proliferation are closer to adult levels than to early developmental levels (Bayer and Altman, 1974; Stanfield and Cowan, 1979) . Granule cells born on postnatal day (P) 14 or later are mostly restricted to the inner layer of the GCL, where adult born cells are found (Stanfield and Cowan, 1979) . Further, by P14 DG stem cells are condensed into the SGZ where adult stem cells reside (Nicola et al., 2015; Sugiyama et al., 2013) . Thus, some studies suggest that "adult" neurogenesis may begin as early as P14, when the DG more closely resembles the adult structure in terms of neurogenesis and anatomical layout (Nicola et al., 2015) . Ongoing changes in DG neurogenesis and structure across its life-long development may underlie the short and long-term effects of environment on this structure.
Environmental exposures during early life can alter DG development, often resulting in persistent deficits in DG neurogenesis and function. Early life insults can be caused by medicinally utilized drugs, illicit substances, infections and psychological stress, among other things. Administering anesthetics or glucocorticoids during the first three postnatal weeks leads to decreased DG cell proliferation and neurogenesis, depletion of the stem cell pool, and increased apoptosis in rodent models (Lu et al., 2017; Yan et al., 2017; Yu et al., 2010; Zhu et al., 2010) . Moreover, the acute reductions in DG cell proliferation and stem cell number caused by early postnatal isoflurane and dexamethasone administration persist for several weeks after the exposure and even into adulthood (Yu et al., 2010 (Yu et al., , 2017b Zhu et al., 2010) . Similarly, ethanol administration and measles infection result in reductions in DG neural stem/precursor cells and neurogenesis, with concurrent increases in apoptosis shortly after the interventions (Fantetti, Gray, Ganesan, Kulkarni, & O'donnell, 2016; Xu et al., 2015) . Further, early life stress caused by maternal separation or erratic maternal care results in decreased DG cell proliferation and neurogenesis shortly after the stress (Baek et al., 2011 (Baek et al., , 2012 Lajud, Roque, Cajero, Gutierrez-Ospina, & Torner, 2012; Oreland, Nylander, & Pickering, 2010) , with the deficits continuing into adulthood (Aisa et al., 2009; Hulshof et al., 2011; Kikusui and Mori, 2009; Leslie et al., 2011; Mirescu, Peters, & Gould, 2004; Naninck et al., 2015; Suri et al., 2013) . The young hippocampus is particularly susceptible to many of these harmful interventions, as similar insults during adolescence or adulthood do not produce as severe or lasting effects on DG stem cells or neurogenesis (Elizalde et al., 2010; Heine, Maslam, Zareno, Joels, & Lucassen, 2004; Lagace et al., 2010; Zhu et al., 2010) . Together, the data suggest that environmental exposures that acutely alter DG development during early life result in long-term and extensive effects on DG neurogenesis.
The direct contribution of the immediate depletion of stem cells and reduction in cell proliferation and neurogenesis to the long-term effects on DG neurogenesis caused by these early life interventions remains unclear. Recent work showed that ablation of dividing stem cells, and consequently reduction of cell proliferation and neurogenesis, for 1 week during adolescence or adulthood does not have a lasting effect on the DG stem cell lineage (Kirshenbaum et al., 2014) . These results parallel studies of drug administration or stress during similar time periods in which there is a recovery of neurogenesis after termination of the intervention (Elizalde et al., 2010; Heine et al., 2004; Lagace et al., 2010; Zhu et al., 2010) . Given the prolonged effects of early life interventions, we hypothesized that the immediate reductions in stem cell number, cell proliferation, and neurogenesis caused by early postnatal insults contribute to the resulting long-term deficits in DG stem cells and neurogenesis since these changes are induced during critical DG developmental periods. Although studies have shown that ablation of proliferating stem cells during or after the fifth postnatal week does not have lasting effects on DG stem cell lineages (Kirshenbaum et al., 2014) , it is unknown if a similar intervention during earlier periods can lead to long-term changes. Here, we examined whether targeting dividing neural stem cells for elimination for 1 week during early life is sufficient to diminish adult neurogenesis, and if the timing of the intervention affects the outcome. We focused on the first and third postnatal weeks because studies of early life interventions commonly used in rodents encompass one or both of these periods and the development and structure of the DG differs during these two-time windows in terms of cell proliferation, birth of surviving neurons, and anatomical structure.
We explored the effect of ablating neural stem cells dividing during the first and third postnatal weeks, then assessed adult DG stem cell lineages and neurogenesis. We found that pharmacogenetic ablation of proliferating GFAP1 cells during the first postnatal week led to fewer adult stem cells and nearly absent neurogenesis, while ablation of proliferating GFAP1 cells during the third postnatal week resulted in reduced neurogenesis, but did not deplete the stem cell pool. Measuring baseline stem cell proliferation during these two-time windows revealed that there are more proliferating stem cells during the first postnatal week compared to the third week. Thus, fewer adult stem cells present following the first week intervention may reflect depletion of the stem cell pool. Similar effects of our pharmacogenetic intervention were identified in male and female mice.
| M A TE RI A L S A ND M E TH ODS

| Animals
All mice were maintained on a 12:12 light cycle (6 am to 6 pm light) and given food and water ad libitum. All procedures were performed in the light cycle and complied with NIH AALAC and NY State Psychiatric Institute IACUC guidelines.
| Breeding
A triple-gene modified mouse line was used for this study. Transgenic mice expressing the gene for herpes thymidine kinase under control of the GFAP promoter (GFAP-Tk; RRID:IMSR_JAX:005698) (Bush et al., 1998) male and female experimental animals. Mice were maintained on a mixed C57Bl/6;Sv129 background. Genotypes were established using PCR as described previously (Bush et al., 1998; Dranovsky et al., 2011; Srinivas et al., 2001 ).
| VGCV treatment
GFAP-Tk 1/2 experimental mice and their littermate Tk 2/2 controls were treated with valganciclovir (VGCV, Aurobindo Pharma) from P0-P7 or from P14-P21. For the P0-P7 group, pups were cross-fostered from GFAP-Tk dams to FVB/NJ (Jackson Laboratory, Cat# 001800)
foster dams between 4 and 6 pm on P0 (defined as the day pups were found). FVB/NJ dams were fed chow containing 700 mg VGCV/kg chow (Custom Animal Diets) starting at least 3 days prior to crossfoster. VGCV chow was available ad libitum to FVB/NJ foster dams until the evening of P7, when it was replaced with standard chow.
FVB/NJ dams consumed an average of 10 g of chow on P0, steadily increasing to 14 g chow on P7, thereby receiving 7-10 mg of VGCV per day across the week. Pups were weaned on P28. For the P14-P21
VGCV treatment group, pups were kept with their original mothers.
Pups underwent oral gavage with VGCV (10 mg kg 21 per dose suspended in dH 2 O) twice daily 8 hr apart starting from the evening of P14 until the evening of P21. Pups were weaned on P28. Mice were separated by sex at weaning. Tk2 and Tk1 animals were cohoused in the same cages.
| CldU injections, tamoxifen administration, and euthanasia
For the P0-P7 VGCV group, chlorodeoxyuridine (CldU, Sigma-Aldrich, 
| GFAP-Tk adult mice
Three sections per animal atlas matched and equally spaced across the anterior-posterior axis of the DG were selected with a 103 objective on the epifluorescence microscope. The entire DG of each chosen section was imaged using the 403 objective on a confocal microscope (Leica TCS SP8). Cells were quantified from images visualized on Leica LAS X Core confocal software (http://www.leica-microsystems.com/ products/microscope-software/details/product/leica-las-x-ls/). All EYFP1 cells or all GFAP 1 EYFP1 cells in chosen sections were manually counted throughout the SGZ, GCL, molecular layer and hilus, and marker co-expression and morphology were manually determined for each cell. EYFP expression facilitated cell quantification as EYFP labels the nucleus, cell body, and processes. Data are reported as sum of cells counted per animal.
| Nestin-KOr mice
Three sections per animal atlas matched and equally spaced across the anterior-posterior axis of the DG were selected using Hoechst counterstain with the 10x objective on the epifluorescence microscope. For P7 animals, one 633 frame was captured using the confocal microscope for each blade (upper and lower) of the DG for each section for a total of six frames. For P21 animals, three 633 frames were captured for each blade of the DG for each section. Confocal images were visualized using Leica LAS X Core software. All KOr 1 GFAP1 cells were manually counted in all captured frames and the number of these cells also expressing MCM2 was manually counted. Two to three hundred KOr 1 GFAP1 cells were counted per animal.
| Statistical analysis
Data were analyzed using GraphPad Prism Software (https://www.
graphpad.com/scientific-software/prism/, RRID: SCR_002798). All data sets are presented as mean 6 standard error of the mean (SEM). Statistical significance was set at p 0.05.
Immunofluorescence data were analyzed using two-way ANOVA with two fixed factors: condition (genotype: Tk-vs. Tk1; sacrifice age: P7 vs. P21) and sex (male vs. female) (Supporting Information Table   S4 ). For experiments with VGCV treatment, P0-P7 treated animals were compared to each other and P14-P21 treated animals were compared to each other. Wherever main effect of sex was observed, male and female animals were analyzed separately using two-tailed, unpaired t tests to determine the effect of condition within sex. For analyses in which there was no main of effect of sex, the two-way ANOVA main effect of condition was used to compare conditions.
| RE S U L TS
| Short-term effects of VGCV treatment on cell proliferation
The goal of this study was to determine if temporally restricted ablation of dividing neural stem cells during early life is sufficient to produce long-term effects on adult stem cell lineages in the DG. We utilized a GFAP-Tk (Bush et al., 1998) mouse line crossed to Nestin-CreER T2 (Dranovsky et al., 2011) and R26R-stop-EYFP (Srinivas et al., 2001) lines as described previously (Kirshenbaum et al., 2014) . Combining the two genetic systems has allowed us to assess the adult stem cell lineage in animals that have undergone prior stem cell ablation (Kirshenbaum et al., 2014 Page: 4 apoptosis (Garcia, Doan, Imura, Bush, & Sofroniew, 2004) . We first sought to determine if our VGCV treatment is effective in reducing cell proliferation and if cell proliferation recovers after cessation of treatment during our experimental time periods as with treatment later in life (Kirshenbaum et al., 2014) . We administered VGCV to pups for 1 week from P0-P7 or from P14-P21 ( Figure  F1 1a,f). VGCV requires oral administration, which created technical challenges for treating nursing pups. For the P0-P7 VGCV treatment, dams were given chow containing VGCV allowing drug delivery via milk to the pups. Because GFAPTk1 males are infertile (Bush et al., 1998) , pups were cross-fostered to non-transgenic FVB/NJ nursing dams in order to avoid the effects of VGCV in Tk1 dams. For P14-P21 VGCV treatment, pups were gav- Figure S1 ). Cellular identity was determined based on marker coexpression and morphological characteristics as described previously (Bonaguidi et al., 2011; Dranovsky et al., 2011; Lagace et al., 2007) ( Figure  F2 2). To identify the neuronal and astrocytic components of the lineage, we stained for doublecortin (DCX), NeuN, and GFAP. DCX and NeuN expression was used to identify immature and mature neurons.
Because DCX is mostly expressed during the first 3 weeks after neuronal birth (Brown et al., 2003) , we categorized all EYFP1 cells that coexpressed DCX as immature neurons (Figure 2a ). EYFP1 cells that coexpressed NeuN, but not DCX, were considered mature neurons ( Figure 2b ). Further, EYFP1 cells that co-expressed GFAP were identified as astrocytes. Because GFAP is expressed by both stem and nonstem astrocytes in the DG, GFAP1 astrocyte types can be distinguished based on their morphology and expression of other markers (Dranovsky et al., 2011; Patrylo and Nowakowski, 1994; Seri, GarciaVerdugo, Collado-Morente, McEwen, & Alvarez-Buylla, 2004 ). GFAP1 cells with somas in the SGZ and a single radial process traversing the GCL were categorized as radial-glial like cells (RGLs) (Figure 2c ). Within the RGL population, those cells co-expressing the stem marker Nestin are neural stem cells (Bonaguidi et al., 2011; Lagace et al., 2007; Seri et al., 2004) . The stem cell potential of Nestin-RGLs remains uncertain (Encinas et al., 2013) . EYFP 1 GFAP1 cells found throughout the DG with multiple similar-sized processes extending from the cell body were classified as non-stem stellate astrocytes (Patrylo and Nowakowski, 1994) (Figure 2d ). Some of these cells also co-expressed the astrocyte marker S100b. A small number of EYFP 1 GFAP1 cells did not exhibit the typical RGL or stellate astrocyte morphology. These cells had a single dominant process and occasionally minor processes extending from the cell body, the somas were found outside the SGZ, and the dominant process was often nonradial. We categorized these cells as atypical astrocytes (Figure 2e ). Some of these atypical astrocytes coexpressed Nestin, while others co-expressed S100b.
Quantitative analysis using a two-way ANOVA showed a main effect of sex for the number of EYFP1 cells in animals treated from P0-P7 and from P14-P21 (Supporting Information Table S4 We next examined the effects of early life VGCV on astrocytes produced by adult stem cells. We quantified the number of EYFP 1 GFAP1 (Figure 3g,h ). These data indicate that elimination of dividing neural stem VGCV decreased the number of RGLs and increased the number of atypical astrocytes, but did not affect the number of stellate astrocytes within the Nestin lineage of Tk1 males and (h) females compared to Tk-animals. (i) P0-P7 VGCV led to fewer Nestin-S100b-and Nestin 1 S100b-RGLs, but did not change the number of S100b1 (including both Nestin-S100b1 and Nestin 1 S100b1) RGLs within the Nestin lineage of Tk1 versus Tk-males. (j) P0-P7 VGCV led to fewer Nestin-S100b-, Nestin 1 S100b-, and S100b1 RGLs within the Nestin lineage of Tk1 versus Tk-females. Scale bar represents 150 lM. GFAP inset is at 32 magnification. Data are expressed as mean 6 SEM. *p 0.05, **p < 0.01, ***p < 0.001 [Color figure can be viewed at wileyonlinelibrary.com] cells during the first postnatal week resulted in alterations in RGL and atypical astrocyte production, but no effect on the stellate astrocyte component of the adult Nestin lineage.
Although a diminished pool of adult RGLs did remain after P0-P7 stem cell ablation, the treated mice almost entirely lacked adult neurogenesis. Moreover, morphologically atypical astrocytes constituted a considerable population in the Tk1 mice raising the possibility that a cell type with unclear stem cell potential was increasingly represented within the Nestin lineage following brief stem cell ablation. These observations raise an intriguing possibility that early life stem cell ablation compromises adult Nestin lineage astrocyte attributes and function. We therefore decided to examine the expression of stem and non-stem astrocyte markers in EYFP 1 GFAP1 astrocytes in our animals. We assessed for expression of Nestin, a marker of stem cells, and S100b, a marker of non- RGLs is unknown (Encinas et al., 2013) . One study has reported that a small population of RGLs express S100b and have diminished stem cell capacity (Gebara et al., 2016) . P0-P7 VGCV treatment led to a reduction in the number of Nestin-S100b-(males: t (4) 5 4.260, p 5 0.013; females: Previously, we reported that elimination of dividing stem cells during early adolescence (P28-P35) did not result in lasting effects on the size of the Nestin lineage (Kirshenbaum et al., 2014) . Given our findings with the P0-P7 treatment above, we sought to establish whether the sensitive period for affecting adult neurogenesis is closed by the third postnatal week, when neurogenesis begins to resemble its adult anatomical restriction (Nicola et al., 2015; Sugiyama et al., 2013) . We assessed the adult Nestin lineage in mice treated with VGCV from P14-P21 (Figure 4a,b) and found that the treatment led to fewer EYFP1 cells in both Tk1 males and females compared to Tk2 animals of each sex (males:
t (10) 5 2.365, p 5 0.0396; females: t (9) 5 4.575, p 5 0.0013) (Figure 4c ,e).
P14-P21 VGCV led to fewer DCX and NeuN expressing neurons (males:
t ( Nestin 1 S100b-: t (6) 5 0.8662, p 5 0.4197; S100b1: t (6) 5 1.015, p 5 0.3492) (Supporting Information Figure S3g ). Tk1 P14-P21 treated females had an increase in the percentage of Nestin 1 S100b-cells within the atypical astrocytes (t (6) 5 2.756, p 5 0.0330) compared to Tk2 females, but no difference was detected in the percentage of Nestin-S100b-(t (6) 5 1.500, p 5 0.1842) or S100b1 cells in this population (t (6) 5 0.4973, p 5 0.6367) (Supporting Information Figure S3i ).
Unlike following P0-P7 VGCV, however, the total number of atypical astrocytes was small in all P14-P21 treated groups (Figure 4g,h) . Lastly, VGCV treatment did not alter the percentage of stellate astrocytes in the lineage that did or did not express S100b1 in males or females (Nestin-S100b-: males: t (6) 5 1.005, p 5 0.3538; females: t (6) 5 0.7869, p 5 0.4613. Nestin-S100b1: males: t (6) 5 1.005, p 5 0.3538; females: Figure S3j ,k).
Together, these results demonstrate that P14-P21 VGCV treatment in males and females reduced adult neurogenesis and created a neural stem cell fate bias toward astrocytic progeny, and that these lineage changes do not simply reflect a depleted neural stem cell pool as the number of adult RGLs was maintained.
| Neural stem cell proliferation during early life
Our results show that VGCV treatment during the first, but not the third, week of life leads to fewer adult stem cells within the Nestin lineage. Because stem cells present in early life are thought to be the source of the adult stem cell pool (Encinas et al., 2013; Li, Fang, Fernandez, & Pleasure, 2013; Nicola et al., 2015; Sugiyama et al., 2013) , the P0-P7 time period may be susceptible to a life-long decrease in RGLs due to the greater number of dividing GFAP1 stem cells available for VGCV targeting during this time. Indeed, postnatal day 6, compared to P3 or P9, has been suggested to be the peak of proliferation for stem cells that remain into adulthood (Ortega-Martinez and Trejo, 2015) .
Therefore, we hypothesized that there are more dividing stem cells during the P0-P7 period compared to the P14-P21 period, and that this difference may underlie the ability of VGCV treatment to reduce the adult stem cell pool after treatment during the earlier time window.
To test this hypothesis directly, we used a transgenic mouse line with expression of a rapidly degrading fluorescent Kusabira Orange (KOr) protein under the control of a Nestin promoter (Ishizuka et al., 2011; Kanki et al., 2010) We previously reported that ablation of proliferating neural stem cells during the fifth postnatal week does not produce lasting effects on the size of the Nestin stem cell lineage (Kirshenbaum et al., 2014) . In this context, our data demonstrating that ablation of dividing stem cells (Aisa et al., 2009; Hulshof et al., 2011; Kikusui and Mori, 2009; Leslie et al., 2011; Mirescu et al., 2004; Naninck et al., 2015; Suri et al., 2013; Yu et al., 2010 Yu et al., , 2017b Zhu et al., 2010) , while the effects of similar interventions during adolescence or adulthood recover after the intervention is terminated (Elizalde et al., 2010; Heine et al., 2004; Lagace et al., 2010; Zhu et al., 2010) .
Sensitive developmental windows for determining stem cell function or response to environmental insults have been previously demonstrated for neural stem cells in multiple brain areas. DG stem and progenitor cells have been shown to be sensitive to the antiproliferative and anti-neurogenic effects of the environmental toxicant methylmercury at P7 and P14, but not P21 (Obiorah, McCandlish, Buckley, & DiCicco-Bloom, 2015) . The temporal restriction of the negative effects of methylmercury to earlier developmental time periods is analogous to the more robust and long-term effects of VGCV treatment earlier in life. Additionally, in normal cortical development, stem cell function changes as the brain assembles. During early cortical development, radial cells predominantly divide symmetrically to expand the stem cell pool, whereas later in development, these cortical stem cells more often undergo differentiating divisions to give rise to neurons (Gotz and Huttner, 2005) . These examples underscore how stem cell lineage specification changes as the brain matures. Hence, interfering with the DG neural stem pool during distinct periods during early development may have distinct outcomes on stem cell lineage trajectories for the life of the animal. In the case of DG neural stem cells, which are exquisitely sensitive to the effects of chronic stress and other environmental insults, these sensitive periods may determine the long-term effects of these insults on neurogenesis. indicating that the effect of this drug on stem cell activity is cellautonomous (Efstathopoulos et al., 2015) . In contrast, both voluntary wheel running and short-term calorie restriction alter molecular niche factors to promote DG neurogenesis without impacting the number of stem cells, demonstrating that neurogenesis can be modulated through environmentally-induced niche effects (Dranovsky et al., 2011; Gremmelspacher, Gerlach, Hubbe, Haas, & Haussler, 2017; Hornsby et al., 2016) .
Interestingly, the long-term effects of early life ablation of dividing stem cells are similar to the effects of hippocampal irradiation, suggesting that the mechanisms underlying these responses may also be analogous. As with early life dividing stem cell ablation, irradiation either during early life or adulthood results in dramatically diminished DG neurogenesis, but maintenance of the stem/progenitor cell pool and preserved gliogenesis (Dranovsky et al., 2011; Mizumatsu et al., 2003; Monje, Mizumatsu, Fike, & Palmer, 2002; Naylor et al., 2008; Rola et al., 2004) . Decreased neurogenesis seen after irradiation is hypothesized to be due mainly to an unsupportive niche (Dranovsky et al., 2011; Monje et al., 2002) . The potential long-term term effects of early life stem cell ablation on DG stem cell-autonomous activity and the stem cell niche, as well as the mechanisms by which these effects occur, require further investigation.
| Sex as a variable largely does not contribute to determining response to VGCV
The effects of VGCV treatment on the adult Nestin lineage are almost indistinguishable between male and female animals for each treatment window, indicating that sex does not contribute to determining the long-term effects of VGCV treatment. However, we did detect a main effect of sex in the number of cells in the Nestin lineage, with more cells in the lineage of female animals. Previous studies using similar methods of lineage tracing found that there are more cells in the Nestin lineage of female compared to male animals 12 days after induction of labeling, but the difference was not statistically significant (Lagace et al., 2007) . In this context, a significant difference in the size of the lineages between sexes 7 weeks after initiation of labeling suggests that the disparity in cell number is accentuated as the lineage accumulates. The larger lineages of female animals could be because (1) there are more Nestin1 stem and progenitor cells available to be labelled initially in females, (2) Nestin1 stem and progenitor cells are more active and produce larger lineages in females, and/or (3) TMX metabolism differs between males and females so that more stem and progenitor cells are initially labelled in females. Regardless of these possibilities, the proportions of neurons and astrocytes in the Nestin lineage of males and females in each treatment group are similar, suggesting similar lineage potentials of DG RGLs between the sexes.
We also found that P0-P7 VGCV females and males differ in the recovery of cell proliferation 1 week after treatment completion. However, the adult effects of P0-P7 VGCV treatment are almost identical in males and females, suggesting that the difference in short-term recovery of cell proliferation does not translate to differences in long-term effects and that the 1-to 2-week suppression of stem cell proliferation during early life is sufficient to produce the long-term effects in both sexes. The continued suppression of cell proliferation in female mice observed 1 week after P0-P7 VGCV suggests that the stem cells or neurogenic niche in females may be more sensitive in the short-term to stem cell ablation at this early age. (Cooper et al., 2015; Dorn et al., 2014; Rees and Inder, 2005) .
These observations parallel persisting hippocampal sequelae of neonatal and juvenile exposure of mice to drugs, infections and psychological stress (McEwen, 2003; Ruddy and Morshead, 2018; Yu, Li, & Yuan, 2017a) . Curiously, these early life manipulations in mice lead to lasting deficits in DG stem cell number and neurogenesis, but the mechanisms by which these persistent changes develop are unknown. In this study, we utilized early life ablation of dividing stem cells to mimic the stem cell depletion, diminished cell proliferation and neurogenesis, and increased apoptosis that occurs immediately or shortly after biological early life insults. We demonstrate that this early postnatal stem cell ablation is sufficient to deplete the adult stem cell pool and decrease adult neurogenesis. Thus, these short-term cellular effects of early postnatal insults have the capacity to produce the long-term DG stem cell lineage deficits. The possibility that these life-long changes in DG neurogenesis and lineage homeostasis contribute to persisting hippocampal dysfunction associated with early life stress remains to be explored.
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